rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lorinda Burgess

Director

Company insider

Files Form 4 as: Director, AngioDynamics; Director, Stepan.

In numbers

Trades disclosed
13
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
27 Apr 2021
Last trade
15 Jul 2026
Last filed
22 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ANGO AngioDynamicsDirector · Medical Devices · last 15 Jul 20260 buys · 0 sells
SCL StepanDirector · Chemicals · last 8 May 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
15 Jul 2026filed 22 Jul 2026ANGO AngioDynamicsMedical DevicesSEC FORM 4 Code A—11,887 at $0.00filing
15 Jul 2026filed 22 Jul 2026ANGO AngioDynamicsMedical DevicesSEC FORM 4 Code A—11,887 at $0.00filing
8 May 2026filed 12 May 2026SCL StepanChemicalsSEC FORM 4 Code A$135K2,566 at $52.61filing
8 May 2026filed 12 May 2026SCL StepanChemicalsSEC FORM 4 Code A$135K2,566 at $52.61filing
16 Jul 2025filed 18 Jul 2025ANGO AngioDynamicsMedical DevicesSEC FORM 4 Code A—17,675 at $0.00filing
12 May 2025filed 13 May 2025SCL Stepanoption or derivative · ChemicalsSEC FORM 4 Code A$136K2,500 at $54.26filing
1 Apr 2025filed 3 Apr 2025SCL Stepanoption or derivative · ChemicalsSEC FORM 4 Code A$55410 at $55.40filing
17 Jul 2024filed 19 Jul 2024ANGO AngioDynamicsMedical DevicesSEC FORM 4 Code A—20,541 at $0.00filing
10 May 2024filed 14 May 2024SCL Stepanoption or derivative · ChemicalsSEC FORM 4 Code A$125K1,396 at $89.53filing
19 Jul 2023filed 21 Jul 2023ANGO AngioDynamicsMedical DevicesSEC FORM 4 Code A—17,041 at $0.00filing
25 Apr 2023filed 27 Apr 2023SCL StepanChemicalsSEC FORM 4 Code A$125K1,325 at $94.32filing
26 Apr 2022filed 28 Apr 2022SCL StepanChemicalsSEC FORM 4 Code A—1,249 at $0.00filing
27 Apr 2021filed 28 Apr 2021SCL StepanChemicalsSEC FORM 4 Code A—760 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Shawn G. LisleVP GC & Secretary · VP GC & Secretary at Stepan Co, filing Form 4 there in the last year
Ruben Dario VelasquezSVP & Chief Financial Officer · SVP & Chief Financial Officer at Stepan Co, filing Form 4 there in the last year
Warren Nighan Jr.SVP Quality and Regulatory · SVP Quality and Regulatory at Angiodynamics, filing Form 4 there in the last year
Chad Thomas CampbellSVP/GM, Vascular Access · SVP/GM, Vascular Access at Angiodynamics, filing Form 4 there in the last year
James C. ClemmerPresident and CEO · President and CEO at Angiodynamics, filing Form 4 there in the last year